Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Gastroenterol Hepatol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    August 2019
  1. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Use of narrative concepts in the EHR to validate genetic determinants of treatment response in a virtual inflammatory bowel disease cohort.
    Clin Gastroenterol Hepatol. 2019 Aug 9. pii: S1542-3565(19)30861.
    PubMed     Text format    


  2. O'CONNOR A, Gracie DJ, Hamlin PJ, Ford AC, et al
    Letter: Predictors of Dyspareunia Among Female Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Aug 8. pii: S1542-3565(19)30854.
    PubMed     Text format    


  3. NAGANUMA M, Kobayashi T, Nasuno M, Motoya S, et al
    Significance of Conducting 2 Types of Fecal Tests in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30843.
    PubMed     Text format     Abstract available


  4. JESS T, Jensen BW, Andersson M, Villumsen M, et al
    Inflammatory Bowel Disease Increases Risk of Type 2 Diabetes in a Nationwide Cohort Study.
    Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30841.
    PubMed     Text format     Abstract available


  5. REINISCH W, Gottlieb K, Colombel JF, Danese S, et al
    Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
    Clin Gastroenterol Hepatol. 2019;17:1673-1679.
    PubMed     Text format     Abstract available


    July 2019
  6. LICHTENSTEIN GR, Shahabi A, Seabury SA, Lakdawalla DN, et al
    Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.
    Clin Gastroenterol Hepatol. 2019 Jul 18. pii: S1542-3565(19)30765.
    PubMed     Text format     Abstract available


  7. LE BERRE C, Ananthakrishnan AN, Danese S, Singh S, et al
    Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment.
    Clin Gastroenterol Hepatol. 2019 Jul 10. pii: S1542-3565(19)30738.
    PubMed     Text format     Abstract available


  8. KISIEL JB, Mahoney DW, Taylor WR, Klepp P, et al
    Response to: Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients (CGH-D-19-01071).
    Clin Gastroenterol Hepatol. 2019 Jul 4. pii: S1542-3565(19)30729.
    PubMed     Text format    


    June 2019
  9. ISRAEL A, Christensen B, El Jurdi K, Rai V, et al
    Follow-Up of Ulcerative Colitis Patients Who Have Achieved Histological Normalization.
    Clin Gastroenterol Hepatol. 2019 Jun 19. pii: S1542-3565(19)30663.
    PubMed     Text format    


  10. LAM SY, Yu J, Peppelenbosch MP
    Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients.
    Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30658.
    PubMed     Text format    


    May 2019
  11. SINGH S, Proudfoot JA, Dulai PS, Xu R, et al
    Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials.
    Clin Gastroenterol Hepatol. 2019 May 17. pii: S1542-3565(19)30529.
    PubMed     Text format     Abstract available


  12. KIRCHGESNER J, Svrcek M, Le Gall G, Landman C, et al
    Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
    Clin Gastroenterol Hepatol. 2019 May 11. pii: S1542-3565(19)30511.
    PubMed     Text format     Abstract available


  13. SANDS BE, Taub PR, Armuzzi A, Friedman GS, et al
    Tofacitinib Treatment is Associated with Modest and Reversible Increases in Serum Lipids in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 May 8. pii: S1542-3565(19)30491.
    PubMed     Text format     Abstract available


  14. GRILLER N, Cohen L
    Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:1213.
    PubMed     Text format    


  15. FRAGAKI M, Demetriou G, Koutroubakis IE
    Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.
    Clin Gastroenterol Hepatol. 2019;17:1213-1214.
    PubMed     Text format    


    April 2019
  16. UNO Y
    Risk of Probiotics: Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Apr 17. pii: S1542-3565(19)30421.
    PubMed     Text format    


  17. WEINTRAUB Y, Cohen S, Chapnik N, Ben-Tov A, et al
    Clock Gene Disruption is an Initial Manifestation of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30373.
    PubMed     Text format     Abstract available


  18. ANANTHAKRISHNAN AN
    Reply to letter to the editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Apr 6. pii: S1542-3565(19)30365.
    PubMed     Text format    


    March 2019
  19. DAI C, Jiang M, Huang YH
    Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Mar 27. pii: S1542-3565(19)30298.
    PubMed     Text format    


  20. EGBERG MD, Galanko JA, Kappelman MD
    Patients Who Undergo Colectomy for Pediatric Ulcerative Colitis at Low-volume Hospitals Have More Complications.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30251.
    PubMed     Text format     Abstract available


  21. KHAN N, Lee H, Trivedi C, Kavani H, et al
    Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30254.
    PubMed     Text format     Abstract available


  22. ZANOLI L
    Increased Cardiovascular Risk in Patients With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:799-800.
    PubMed     Text format    


    February 2019
  23. BURISCH J, Jess T
    Does eradication of Helicobacter pylori cause inflammatory bowel disease?
    Clin Gastroenterol Hepatol. 2019 Feb 12. pii: S1542-3565(19)30153.
    PubMed     Text format    


  24. GRACIE DJ, Ford AC
    Functional Gastrointestinal Symptoms in Inflammatory Bowel Disease: Rising to the Challenge.
    Clin Gastroenterol Hepatol. 2019;17:572-573.
    PubMed     Text format    


  25. MINER PB JR
    Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Feb 1. pii: S1542-3565(19)30137.
    PubMed     Text format    


    January 2019
  26. FALECK DM, Winters A, Chablaney S, Shashi P, et al
    Shorter Disease Duration is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease but Not Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Jan 5. pii: S1542-3565(19)30013.
    PubMed     Text format     Abstract available


    December 2018
  27. RESTELLINI S, Chao CY, Martel M, Barkun A, et al
    Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis-a Systematic Review.
    Clin Gastroenterol Hepatol. 2018 Dec 21. pii: S1542-3565(18)31397.
    PubMed     Text format     Abstract available


  28. MA C, Kotze PG, Almutairdi A, Jairath V, et al
    Concomitant Use of Aminosalicylates Is Not Associated with Improved Outcomes in Patients with Ulcerative Colitis Escalated to Vedolizumab.
    Clin Gastroenterol Hepatol. 2018 Dec 7. pii: S1542-3565(18)31341.
    PubMed     Text format    


  29. WEAVER KN, Long MD
    Preventive Medicine in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31331.
    PubMed     Text format     Abstract available


    November 2018
  30. SANDBORN WJ, Panes J, D'Haens GR, Sands BE, et al
    Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
    Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31278.
    PubMed     Text format     Abstract available


  31. BERINSTEIN JA, Steiner CA, Regal RE, Allen JI, et al
    Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Nov 17. pii: S1542-3565(18)31265.
    PubMed     Text format    


  32. TARGOWNIK LE, Benchimol EI, Bernstein CN, Singh H, et al
    Upfront Combination Therapy, Compared with Monotherapy, for Patients Not Previously Treated with a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31246.
    PubMed     Text format     Abstract available


    October 2018
  33. AXELRAD JE, Olen O, Askling J, Lebwohl B, et al
    Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.
    Clin Gastroenterol Hepatol. 2018 Oct 30. pii: S1542-3565(18)31025.
    PubMed     Text format     Abstract available


  34. VANDE CASTEELE N, Jeyarajah J, Jairath V, Feagan BG, et al
    Infliximab Exposure-Response Relationship and Thresholds Associated with Endoscopic Healing in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Oct 26. pii: S1542-3565(18)31200.
    PubMed     Text format     Abstract available


  35. DAI C, Jiang M, Sun MJ
    The Association Between Consumption of Sweetened Beverages and the Risk of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018;16:1681-1682.
    PubMed     Text format    


  36. GOLDSMITH JR, Sartor RB
    Opioid Toxicity in Inflammatory Bowel Disease Patients Likely Includes Direct Enterocyte Effects That Exacerbate Disease.
    Clin Gastroenterol Hepatol. 2018;16:1679-1680.
    PubMed     Text format    


    September 2018
  37. HART AL, Bouri S
    Onset of action of Inflammatory Bowel Disease medications: how quickly do they really work?
    Clin Gastroenterol Hepatol. 2018 Sep 19. pii: S1542-3565(18)31012.
    PubMed     Text format    


  38. MORILLA I, Uzzan M, Laharie D, Cazals-Hatem D, et al
    Colonic microRNA Profiles, Identified by a Deep-learning Algorithm, That Predict Responses of Patients With Acute Severe Ulcerative Colitis to Therapy.
    Clin Gastroenterol Hepatol. 2018 Sep 14. pii: S1542-3565(18)30947.
    PubMed     Text format     Abstract available


  39. PELLET G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, et al
    Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination with Vedolizumab in Patients With Refractory Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Sep 10. pii: S1542-3565(18)30966.
    PubMed     Text format     Abstract available


  40. RAFFALS LE, Nguyen GC, Rubin DT, Nguyen GC, et al
    Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30943.
    PubMed     Text format    


  41. SOMINENI HK, Kugathasan S
    The microbiome in inflammatory bowel disease: from prevailing clinical evidence to future possibilities.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30957.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: